Cargando…

Targeting the cell cycle for prognosis and therapy of breast cancer

Detalles Bibliográficos
Autores principales:	Keyomarsi, K, Akli, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233488/ http://dx.doi.org/10.1186/bcr1067

Ejemplares similares

The EGF receptor family as targets for breast cancer therapy
por: Baselga, J
Publicado: (2000)

Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer
por: Dowsett, M
Publicado: (2005)

Differentiation therapy: targeting breast cancer stem cells to reduce resistance to radiotherapy and chemotherapy
por: Roy, R, et al.
Publicado: (2010)

Tumour-selective transcriptional targeting for breast cancer gene therapy
por: Hurst, HC
Publicado: (2000)

Prognosis of small screen-detected invasive breast cancers
por: Ellis, I
Publicado: (2008)

Gene pathways associated with prognosis and chemotherapy sensitivity in different molecular subtypes of breast cancer
por: Pusztai, L
Publicado: (2011)

Adjuvant therapy of HER2(+ )breast cancer
por: Winer, EP
Publicado: (2009)

Telomerase: a breast cancer chemopreventive and therapeutic target
por: Shay, JW
Publicado: (2000)

Targeting HER2 in breast cancer: beyond trastuzumab
por: Winer, EP
Publicado: (2011)

Predicting response/resistance to endocrine therapy for breast cancer
por: Miller, WR, et al.
Publicado: (2005)

Adjuvant therapy after preoperative treatment for breast cancer
por: Ciruelos, E
Publicado: (2009)

Increased immunogenicity of HIV vaccination with constant-current electroporation and molecular adjuvants in mice and rhesus macaques
por: Hirao, Lauren, et al.
Publicado: (2006)

Combined hormonal therapy for advanced breast cancer in postmenopausal patients
por: Langecker, P, et al.
Publicado: (2003)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

Vaccine targeting HIF1A in triple negative breast cancer
por: Cecil, Denise, et al.
Publicado: (2014)

Stem cells in normal breast development and breast cancer
por: Wicha, MS, et al.
Publicado: (2003)

Low-molecular-weight cyclin E: the missing link between biology and clinical outcome
por: Akli, Said, et al.
Publicado: (2004)

Characterization of specific HHV-6 and cell cycle genes implicated in virus-mediated G1/S cell-cycle arrest of glial precursors
por: Mock, David J, et al.
Publicado: (2006)

Suppression of the NF-κB cofactor Bcl3 inhibits mammary epithelial cell apoptosis and, in breast tumours, correlates with poor prognosis
por: Wakefield, A, et al.
Publicado: (2008)

Long-term survival of interval breast cancers in breast cancer screening in Wales
por: Fong, YF, et al.
Publicado: (2012)

Stem cells in human breast development and cancer
por: Wicha, M, et al.
Publicado: (2005)

Steroid regulation of breast cancer cell proliferation
por: Sutherland, RL
Publicado: (2003)

Tibial acceleration variability during consecutive gait cycles is influenced by the menstrual cycle
por: Bartold, Simon, et al.
Publicado: (2011)

Construction of transgene-amplified CHO cell lines by cell cycle checkpoint engineering
por: Lee, Kyoung Ho, et al.
Publicado: (2013)

Translational breast cancer research in luminal breast cancer
por: Dowsett, M
Publicado: (2011)

A10 OVEREXPRESSION OF ASCL2 ALTERS DIFFERENTIATION, CELL CYCLE AND RESISTANCE TO ANTI-CANCER TREATMENT IN ESOPHAGEAL ORGANOIDS
por: Hamilton, M, et al.
Publicado: (2023)

Back to the cell cycle with SAMHD1 and its viral antagonist, Vpx
por: Margottin-Goguet, Florence
Publicado: (2013)

Targeting secreted heat shock protein-90alpha (Hsp90α) to prevent breast cancer progression
por: Zhao, Zhengwei, et al.
Publicado: (2010)

Functional characterization of mammary stem cells in development and breast cancer
por: Rosen, JM, et al.
Publicado: (2003)

Activation of TGF-beta signalling in breast cancer metastatic cells
por: Giampieri, S, et al.
Publicado: (2008)

Abdominal and pelvic complications of molecular targeted therapy
por: Gore, Richard M, et al.
Publicado: (2014)

Epigenetics of breast cancer
por: Esteller, M
Publicado: (2011)

Use of mouse models to validate and therapeutically target transforming growth factor beta as an important player in breast cancer progression
por: Wakefield, LM, et al.
Publicado: (2003)

The role of the tumor microenvironment in breast cancer progression
por: Min, H, et al.
Publicado: (2005)

Circulating tumor cells and novel biomarkers for prognostic and biological of breast cancer
por: Cristofanilli, M
Publicado: (2005)

Validation of a new automated volumetric breast density measurement system as a marker of breast cancer risk
por: Pinker, K, et al.
Publicado: (2010)

Molecular mechanisms of resistance to HER2-targeted therapy
por: Esteva, FJ
Publicado: (2009)

Aberrant activation of Notch signalling in human breast cancer
por: Stylianou, S, et al.
Publicado: (2006)

The future of breast cancer prevention
por: Howell, A, et al.
Publicado: (2005)

Genomic profiling of breast cancer
por: Borg, Å
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_cnm6f1ub2kt7d4m2s06f5iam9s